Concepedia

Luděk Pour

LP

Statistics

Publications

11

Citations

377

H-Index

11

Active since

2005

Affiliations

National and Kapodistrian University of Athens(Current)

University Hospital Brno

Ocní klinika

Masaryk University

Navarre Institute of Health Research

Luděk Pour is an author at National and Kapodistrian University of Athens specializing in medicine, pharmacotherapy, and multiple myeloma.

Publications per year

2005–2025

11

Publications

11

Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma

Meletios Α. Dimopoulos, Meral Beksac, Luděk Pour et al. · New England Journal of Medicine · 2024 · 151 citations

, , +15

Carfilzomib–dexamethasone vs bortezomib–dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR

W-J Chng, Hartmut Goldschmidt, Meletios Α. Dimopoulos et al. · Leukemia · 2016 · 58 citations · Full text

, , +16

Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma – Phase II study results

L Zahradová, Klára Mollová, Darina Očadlíková et al. · Neoplasma · 2012 · 33 citations · Full text

, , +17

Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study

Niels W.C.J. van de Donk, Monique C. Minnema, Bronno van der Holt et al. · The Lancet Oncology · 2023 · 26 citations · Full text

, , +9

Plasma Concentrations of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor in Lymphoproliferative Disorders

Lukáš Smolej, Ctirad Andrýs, Vladimír Maisnar et al. · Acta Medica (Hradec Kralove Czech Republic) · 2005 · 20 citations · Full text

, , +12

1–5 of 11